ENFLONSIA (Clesrovimab) RSV Monoclonal Antibody Clinical Trials, Dosage, Indication, Side Effects
Merck's ENFLONSIA (Clesrovimab, MK-1654) is an approved, extended half-life monoclonal antibody (mAb) developed as a passive immunization to... Read more...